Facilities & Manufacture

BAC’s production plant in Naarden has been built to an advanced engineering level, satisfying international standards for ‘Hygienic Processing’ and for the handling of Genetically Modified Micro-organisms and Bioproducts.

The manufacturing process performed to produce the single domain antibodies in yeast is completely free of animal derived components. BAC’s facility includes 15 cbm reactors and a newly commissioned separation suite, allowing for rapid scale up and efficient industrial production of the affinity ligands.